Watchdog rules that Merck violated the UK industry code of practiceBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7537.323-a (Published 09 February 2006) Cite this as: BMJ 2006;332:323
- Owen Dyer
The UK pharmaceutical industry's regulatory watchdog has ruled that Merck violated the industry's code of practice by altering guidelines on hypertension treatment to give greater prominence to one of the company's own drugs.
The “ABCD” algorithm is intended to inform decisions on prescribing for high blood pressure in the guidelines of the British Hypertension Society, which were first published in the BMJ in March 2004 (BMJ 2004;328:634-40).
The letter A refers to angiotensin converting enzyme inhibitors and angiotensin receptor blockers, and the two types of drug are listed in the guidelines in that order. The guidelines specify that “all things being equal and when there are no compelling indications for …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial